Pre-treatment characteristics and long-term outcomes of recurrent-metastatic head and neck cancer patients treated with immune checkpoint inhibitors

被引：1
|
作者：
Issa, M. [1 ]
Schultz, T. [1 ]
Xu, M. [1 ]
Bhateja, P. [1 ]
Karivedu, V. [1 ]
Dibs, K. [2 ]
Old, M. [3 ]
Kang, S. [3 ]
Gamez, M. [2 ]
Grecula, J. [2 ]
Jhawar, S. [2 ]
Mitchell, D. [2 ]
Seim, N. [3 ]
Agrawal, A. [3 ]
Ozer, E. [3 ]
Baliga, S. S. B. E. [2 ]
Carrau, R. [3 ]
Rocco, J. [3 ]
Blakaj, D. [2 ]
Bonomi, M. [1 ]
机构：
[1] Ohio State Univ, Comprehens Canc Ctr James, Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Comprehens Canc Ctr James, OSUCCC, Radiat Oncol Dept, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Hosp, Otolaryngol, Columbus, OH 43210 USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
948P
引用
收藏
页码：S674 / S675
页数：2
相关论文
共 50 条
  • [1] Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
    Bila, Michel
    Franken, Amelie
    Van Dessel, Jeroen
    Garip, Melisa
    Meulemans, Jeroen
    Willaert, Robin
    Hoeben, Ann
    Vander Poorten, Vincent
    Clement, Paul M.
    ORAL ONCOLOGY, 2024, 149
  • [2] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Takuma Matoba
    Kiyoshi Minohara
    Daisuke Kawakita
    Gaku Takano
    Keisuke Oguri
    Akihiro Murashima
    Kazuyuki Nakai
    Sho Iwaki
    Hiroshi Tsuge
    Nobukazu Tanaka
    Sae Imaizumi
    Wataru Hojo
    Ayano Matsumura
    Koji Tsukamoto
    Shinichi Esaki
    Shinichi Iwasaki
    Scientific Reports, 12
  • [3] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Matoba, Takuma
    Minohara, Kiyoshi
    Kawakita, Daisuke
    Takano, Gaku
    Oguri, Keisuke
    Murashima, Akihiro
    Nakai, Kazuyuki
    Iwaki, Sho
    Tsuge, Hiroshi
    Tanaka, Nobukazu
    Imaizumi, Sae
    Hojo, Wataru
    Matsumura, Ayano
    Tsukamoto, Koji
    Esaki, Shinichi
    Iwasaki, Shinichi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] High pre-treatment NLR and PLR predict poor prognosis of patients with recurrent/metastatic head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Anile, Giuseppe
    Gottardi, Chiara
    Micheletto, Ilaria
    Nicolai, Piero
    El Khouzai, Badr
    Ferrari, Marco
    Ghirelli, Angelica
    Pretto, Greta
    Guarneri, Valentina
    Ghi, Maria Grazia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Long term outcomes in patients with recurrent/metastatic (R/M) salivary gland cancer (SGC) treated with immune checkpoint inhibitors (ICI)
    Shih, Lauren
    Wu, Vicky
    Ng, Kevin
    Voutsinas, Jenna M.
    Dumenigo-Jimenez, Ariana
    Fromm, Jonathan R.
    Martins, Renato G.
    Eaton, Keith D.
    Santana-Davila, Rafael
    Baik, Christina S.
    Lee, Sylvia
    Tseng, Diane
    Deng, Lei
    Barber, Brittany
    Marchiano, Emily
    Laramore, George E.
    Liao, Jay Justin
    Lo, Simon S.
    Parvathaneni, Upendra
    Rodriguez, Cristina P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Letter to the Editor: "Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma"
    Haridevamuthu, B.
    ORAL ONCOLOGY, 2024, 156
  • [7] Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
    Zhu, Alec
    Garcia, Jorge Alberto
    Faltas, Bishoy
    Grivas, Petros
    Barata, Pedro
    Shoag, Jonathan E.
    JAMA NETWORK OPEN, 2023, 6 (04)
  • [8] Clinical predictors for survival with the addition of chemotherapy in patients with recurrent-metastatic squamous cell carcinoma of the head and neck after progression on immune checkpoint inhibitors
    Issa, M.
    Klamer, B.
    Bhateja, P.
    Karivedu, V.
    Laliotis, G.
    Dibs, K.
    Mladkova, N.
    Pan, X.
    Old, M.
    Gamez, M.
    Grecula, J.
    Jhawar, S.
    Mitchell, D.
    Baliga, S.
    Carrau, R.
    Rocco, J.
    Bonomi, M.
    Blakaj, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S797 - S798
  • [9] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
    Hyera Kim
    Minsuk Kwon
    Binnari Kim
    Hyun Ae Jung
    Jong-Mu Sun
    Se-Hoon Lee
    Keunchil Park
    Myung-Ju Ahn
    BMC Cancer, 20
  • [10] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
    Kim, Hyera
    Kwon, Minsuk
    Kim, Binnari
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Park, Keunchil
    Ahn, Myung-Ju
    BMC CANCER, 2020, 20 (01)
12345